Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases
CF Anderson, ME Grimmett… - Wiley Interdisciplinary …, 2020 - Wiley Online Library
Respiratory illnesses are prevalent around the world, and inhalation‐based therapies
provide an attractive, noninvasive means of directly delivering therapeutic agents to their site …
provide an attractive, noninvasive means of directly delivering therapeutic agents to their site …
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …
Inhaled drug delivery: Past, present, and future
Inhaled drug delivery has been an emerging route for the treatment of lung diseases with
clear advantages over oral and intravenous routes. However, the delivery efficacy is affected …
clear advantages over oral and intravenous routes. However, the delivery efficacy is affected …
Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …
based approaches aimed to tackle pulmonary ailments in recent years. The current …
Nano-therapeutics for the lung: state-of-the-art and future perspectives
Inhalation of aerosolized compounds is a popular, non-invasive route for the targeted
delivery of therapeutic molecules to the lung. Various types of nanoparticles have been used …
delivery of therapeutic molecules to the lung. Various types of nanoparticles have been used …
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches
Pulmonary delivery of nanomedicines is very promising in lung local disease treatments
whereas several physiological barriers limit its application via the interaction with inhaled …
whereas several physiological barriers limit its application via the interaction with inhaled …
Therapeutic nanostructures for pulmonary drug delivery
Y Javadzadeh, S Yaqoubi - Nanostructures for drug delivery, 2017 - Elsevier
Pulmonary drug delivery has attracted tremendous interest in the past two decades. In order
to get both local and systemic effects, lungs as the main part of the respiratory system offer …
to get both local and systemic effects, lungs as the main part of the respiratory system offer …
Medical nanoparticles for next generation drug delivery to the lungs
SH van Rijt, T Bein, S Meiners - 2014 - Eur Respiratory Soc
Respiratory diseases are an increasing burden for the ageing population. Although our
understanding of these diseases has improved significantly over the past decades …
understanding of these diseases has improved significantly over the past decades …
Nanomedicines targeting respiratory injuries for pulmonary disease management
The respiratory system holds crucial importance in the biology of vertebrate animals. Injuries
of the respiratory system caused by viral infections (eg, by COVID‐19, MERS, and SARS) …
of the respiratory system caused by viral infections (eg, by COVID‐19, MERS, and SARS) …
Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges
The inhaled delivery of nanomedicines can provide a novel, non-invasive therapeutic
strategy for the more localised treatment of lung-resident diseases and potentially also …
strategy for the more localised treatment of lung-resident diseases and potentially also …